Skip to main content
. 2020 Jul 24;11(4):1020–1076. doi: 10.1111/jdi.13306

Table 13.

Glycemic control targets

Level of control Ideal (non‐diabetes) Appropriate Inappropriate (intervention suggested) High risk (intervention required)
Clinical evaluation
Hyperglycemia Not present Asymptomatic Polydipsia, polyuria and/or enuresis Visual impairment, poor weight gain, growth impairment, late puberty, poor school attendance, skin or pudendal infection, and/or angiopathy
Hypoglycemia Not present No severe hypoglycemia Severe hypoglycemia (impaired consciousness, convulsion)
Biochemical evaluation
SMBG value (mg/dL)
Early morning/preprandial value 65–100 90–145 >145 >162
PG* value (mg/dL)
PPG** 80–126 90–180 180–250 >250
Bedtime PG 80–100 120–180 <120 or 180–200 <80 or >200
Nighttime PG 65–100 <80–161 <75 or >162 <70 or >200
HbA1c (%) <6.5 <7.5 7.5–9.0 >9.0

*PG, plasma glucose; **PPG, postprandial plasma glucose.

(1) All values given above are intended as a guide only and the glycemic control target should be determined individually to ensure it will not be associated with severe hypoglycemia or frequent mild‐to‐moderate hypoglycemia and will help achieve glycemic control as near‐normal as possible in each patient. (2) All values given above should be modified for each patient depending on whether he/she has a prior history of severe hypoglycemia or hypoglycemia unawareness. (3) PG value is given as plasma glucose value in self‐monitoring of blood glucose (SMBG). (Adapted from Rewers M et al. Pediatr Diabetes 2014 16 ).